Sign in

Richard Ashworth

President and Chief Executive Officer at AMEDISYS
Board
Since April 10, 2023
Age
50 years
Tenure
Joined as President and Chief Executive Officer on April 10, 2023, and has held significant leadership roles in the healthcare industry prior to joining, including positions at Tivity Health and Walgreen Co.

Also at AMEDISYS

SGG
Scott G. Ginn
Chief Operating Officer
DB
Denise Bohnert
Chief Compliance Officer
JGG
Jennifer Guckert Griffin
Chief Legal Officer

About

Richard Ashworth is a seasoned healthcare executive and pharmacist with over 30 years of industry experience, and he is 50 years old as of April 29, 2025.

He assumed the role of President and Chief Executive Officer at Amedisys on April 10, 2023, building on a career that includes leading positions such as CEO at Tivity Health and various executive roles at Walgreen Co..

His extensive background in operational management, strategic development, and transformational leadership—highlighted by his work with strategic partners like Alliance Boots—underscores his capability to drive growth and innovation within the healthcare sector.

$AMED Performance Under Richard Ashworth

Past Roles

OrganizationRoleDate RangeDetails
Tivity Health President and CEO; Board Member June 2020 - April 2023 Held concurrently as a Board Member
Walgreen Co. President February 2020 - June 2020 Responsible for developing strategies and plans for all Walgreens operations
Walgreen Co. President of Operations November 2017 - February 2020 N/A
Walgreen Co. President of Pharmacy and Retail Operations 2014 - 2017 N/A
Walgreen Co. Led Healthcare Strategy for Alliance Boots Partnership 2013 Developed and delivered the healthcare strategy leading to Walgreens' acquisition of Alliance Boots

Fixed Compensation

Data from  FY 2023
Component NameAmountPayment ScheduleAdditional Details
Annual Base Salary $1,000,000 AnnuallyFixed cash compensation
Annual Time-Based Stock Options $1,250,000 Vestes one-third each year starting on February 20, 202433,711 options at an exercise price of $79.82 per share
Annual Time-Based RSUs $1,250,000 Vestes one-third each year starting on February 20, 202415,661 RSUs
One-Time Time-Based RSUs $2,500,000 100% vesting on April 12, 202431,321 RSUs
Special Equity Award (Time-Based RSUs) $2,500,000 Vestes ratably over three years from June 26, 202327,410 RSUs
One-Time Cash Payment for Relocation and Expenses $250,000 One-time paymentFor relocation and expenses

Performance Compensation

Data from  FY 2023

Annual Incentive (Cash Bonus) Plan

MetricDetails
Performance MeasureAdjusted EBITDA for 2023
Threshold$216.2 million
Target$240.2 million
Stretch/Maximum$264.2 million
Payout CalculationDollar-for-dollar increments between threshold-target and target-stretch
TSR Modifier75% (25th percentile and below), 100% (50th percentile), 125% (75th percentile and above)
Maximum Payout200% of the target bonus
Vesting ScheduleCliff vest at the end of the three-year performance period ending December 31, 2025
Grant DateApril 12, 2023
Target Bonus$1,000,000 (100% of base salary)

Annual Performance-Based RSUs

MetricDetails
Performance MeasureAdjusted EBITDA for fiscal 2023
Threshold75% of target performance at $216.2 million
Target100% at $240.2 million
Stretch/MaximumUp to 200% at $264.2 million
RSUs Granted (Target)31,321 RSUs
RSUs Granted (Maximum)62,642 RSUs
Actual Achievement127.23% of target based on adjusted EBITDA of $247.0 million
Vesting ScheduleCliff vest on February 20, 2026

One-Time Performance-Based RSUs

MetricDetails
Grant DateApril 12, 2023
Grant Date Fair Value$5,000,000
RSUs Granted (Target)62,641 RSUs
Payout Range50% at threshold, 100% at target, up to 300% at maximum
Vesting ScheduleCliff vest on April 12, 2028
Performance ConditionBased on the Company’s VWAP market cap as of April 12, 2026